Taek Chung

610 total citations
28 papers, 381 citations indexed

About

Taek Chung is a scholar working on Surgery, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Taek Chung has authored 28 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Taek Chung's work include Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Taek Chung is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Taek Chung collaborates with scholars based in South Korea, United States and Singapore. Taek Chung's co-authors include Young Nyun Park, Jeong Eun Yoo, Hyungjin Rhee, Youngsic Jeon, Ji Hee Lee, Moonsik Kim, Woo Hee Jung, Ja Seung Koo, Ji‐Ye Kim and Ji Hae Nahm and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Taek Chung

26 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taek Chung South Korea 11 178 106 86 78 77 28 381
Jonathan Kessler United States 9 105 0.6× 160 1.5× 60 0.7× 32 0.4× 98 1.3× 41 389
Lindy K. Alles Netherlands 10 58 0.3× 71 0.7× 96 1.1× 77 1.0× 88 1.1× 16 351
Jinzhang Chen China 10 60 0.3× 116 1.1× 90 1.0× 75 1.0× 106 1.4× 32 380
Katherine J. Blair United States 11 64 0.4× 128 1.2× 138 1.6× 84 1.1× 55 0.7× 17 389
Young-Joo Shin South Korea 10 122 0.7× 65 0.6× 92 1.1× 41 0.5× 40 0.5× 28 349
Ralf Jesenofsky Germany 12 143 0.8× 258 2.4× 105 1.2× 67 0.9× 57 0.7× 21 452
Siong‐Seng Liau United Kingdom 11 129 0.7× 178 1.7× 160 1.9× 116 1.5× 32 0.4× 29 422
Xiangjun Xie China 10 164 0.9× 111 1.0× 130 1.5× 57 0.7× 85 1.1× 17 407

Countries citing papers authored by Taek Chung

Since Specialization
Citations

This map shows the geographic impact of Taek Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taek Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taek Chung more than expected).

Fields of papers citing papers by Taek Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taek Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taek Chung. The network helps show where Taek Chung may publish in the future.

Co-authorship network of co-authors of Taek Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Taek Chung. A scholar is included among the top collaborators of Taek Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taek Chung. Taek Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeon, Youngsic, Taek Chung, Young Nyun Park, et al.. (2025). Notoginsenoside Ft1 induces lysosomal cell death and apoptosis by inhibiting the PI3K/AKT/mTOR pathway in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 188. 118181–118181. 2 indexed citations
2.
Chung, Taek, Sea‐Kwan Oh, Jeong Eun Yoo, et al.. (2025). Genomic and transcriptomic signatures of sequential carcinogenesis from papillary neoplasm to biliary tract cancer. Journal of Hepatology. 83(1). 119–130.
3.
Lee, Choong‐kun, Taek Chung, Deepak Bhamidipati, et al.. (2025). Impact of HER2-positivity on prognosis and targeted therapeutic outcomes in advanced biliary tract cancer.. Journal of Clinical Oncology. 43(4_suppl). 629–629. 1 indexed citations
4.
Kwon, So Mee, Taek Chung, Jeong Eun Yoo, et al.. (2024). Transcriptomic profiling of intermediate cell carcinoma of the liver. Hepatology Communications. 8(8). 3 indexed citations
5.
Han, Kyunghwa, et al.. (2024). Prediction of PD-L1 expression in unresectable hepatocellular carcinoma with gadoxetic acid-enhanced MRI. European Journal of Radiology. 181. 111772–111772. 1 indexed citations
6.
Soon, Gwyneth Shook Ting, Francesco Callea, Alastair D. Burt, et al.. (2024). Steatohepatitic hepatocellular Carcinoma:A new approach to classifying morphological subtypes of hepatocellular carcinoma. Human Pathology. 149. 55–65. 2 indexed citations
7.
Chung, Taek & Young Nyun Park. (2022). Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma. Frontiers in Medicine. 9. 857140–857140. 47 indexed citations
9.
Jeon, Youngsic, Jeong Eun Yoo, Taek Chung, et al.. (2022). Albumin, filamin-A and cytokeratin 19 help distinguish intrahepatic cholangiocarcinoma from extrahepatic adenocarcinoma. Hepatology International. 17(1). 77–85. 4 indexed citations
10.
Chung, Taek, Hyungjin Rhee, Hyo Sup Shim, et al.. (2021). Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern. Gut and Liver. 16(4). 613–624. 19 indexed citations
11.
Jeon, Youngsic, Jeong Eun Yoo, Hyungjin Rhee, et al.. (2021). YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behavior. Experimental & Molecular Medicine. 53(6). 1055–1067. 17 indexed citations
12.
Rhee, Hyungjin, Taek Chung, Jeong Eun Yoo, et al.. (2020). Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression. Hepatology International. 14(2). 239–248. 33 indexed citations
13.
Kim, Hye Jin, Mi‐Suk Park, Taek Chung, Bohyun Kim, & Jei Hee Lee. (2019). Multimodality imaging studies of intraductal tubulopapillary neoplasms of the pancreas. Diagnostic and Interventional Radiology. 25(4). 251–256. 6 indexed citations
15.
Yoon, Sarah, Eun‐Ju Lee, Ji Hye Choi, et al.. (2018). Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer. Oncogene. 37(32). 4443–4454. 10 indexed citations
16.
Chung, Taek, Sung‐Im Do, Kiyong Na, et al.. (2018). Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine Cervix. Anticancer Research. 38(6). 3551–3558. 19 indexed citations
17.
Chung, Taek, et al.. (2018). Recurrent Indeterminate Dendritic Cell Tumor of the Skin. Journal of Pathology and Translational Medicine. 52(4). 243–247. 2 indexed citations
18.
Chung, Taek, Hyungjin Rhee, Young‐Joo Kim, et al.. (2018). Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis. Gut and Liver. 13(1). 83–92. 19 indexed citations
19.
Chung, Taek, et al.. (2017). Extraosseous Ewing's Sarcoma Presented as a Rectal Subepithelial Tumor: Radiological and Pathological Features. Investigative Magnetic Resonance Imaging. 21(1). 51–51.
20.
Pyo, Soonjae, et al.. (2013). Batch fabricated flexible tactile sensor based on carbon nanotube-polymer composites. 74. 1004–1007. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026